share_log

TCR2 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE K2 Principal Fund, L.P.(5.05%),K2 Genpar 2017 Inc.(5.05%), etc.

Aug 31, 2022 18:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more